ArticleRevista da Associacao Medica Brasileira (1992)2025
Combination of cyclin-dependent kinase 4/6 inhibitors and renin-angiotensin system inhibitors in breast cancer treatment: a promising therapeutic approach.
Emel Mutlu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.